May 01, 2025

FDA Approves Intranasal DHE for Acute Migraine Relief

The FDA has approved Atzumi for the acute treatment of migraine with or without aura in adults.

Conexiant

May 01, 2025

Psilocybin Shows Promise for Parkinson's Disease

First clinical trial demonstrates psilocybin therapy significantly improves depression, anxiety, and motor symptoms.

Conexiant

April 30, 2025

Sitting Raises Neck Pain Risk by Over 80%

"Targeted preventative measures, particularly for high-risk groups like [women] and employees, are necessary."

Conexiant

April 29, 2025

Obesity Independently Hinders Remission in RA

Study shows BMI above 30 correlates with poorer treatment outcomes regardless of comorbidities

Conexiant

April 29, 2025

Nerve Blocks Compared for Knee Replacement

"The ACB group seemed to have some advantages in the rapid postoperative quadriceps muscle strength recovery."

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant

April 24, 2025

Old Drug, New Trick for Joint Pain

Can a common diabetes drug double as a treatment for knee osteoarthritis?

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 22, 2025

Heavy Metals Found in Toothpaste

There are some "heavy metals that are essential in small quantities but could result in adverse effects if present in excess."

Conexiant